Development and evaluation of proniosomes to enhance the transdermal delivery of cilostazole and to ensure the safety of its application

References

• Hamburg NM, Creager MA. Pathophysiology of intermittent claudication in peripheral artery disease. Circ J. 2017;81(3):281–289.
   PubMed Web of Science ®Google Scholar
• Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344(21):1608–1621.
   PubMed Web of Science ®Google Scholar
• Jinno JI, Kamada N, Miyake M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release. 2006;111(1–2):56–64.
   PubMed Web of Science ®Google Scholar
• Baek N, Oh G-H, Park C, et al. Reprecipitation of poorly water-soluble cilostazol crystals using adsorbing carriers for enhanced dissolution and physicochemical modification. J Drug Deliv Sci Technol. 2018;43:477–486.
   Web of Science ®Google Scholar
• Hwang KM, Byun W, Cho CH, et al. Preparation and optimization of glyceryl behenate-based highly porous pellets containing cilostazol. Pharm Dev Technol. 2018;23(5):540–551.,
   PubMed Web of Science ®Google Scholar
• Bhowmik D, Bhattacharjee C, Chandira M, et al. Recent advances in transdermal drug delivery system. Int J PharmTech Res. 2010;2:68–77.
   Google Scholar
• Desmet E, Van Gele M, Lambert J. Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders. Expert Opin Drug Deliv. 2017;14(1):109–122.
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mishra V, Rawat A, et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm. 2005;293(1–2):73–82.
   PubMed Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm. 2011;77(1):43–55.
   PubMed Web of Science ®Google Scholar
• Aboelwafa AA, El-Setouhy DA, Elmeshad AN. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. AAPS PharmSciTech. 2010;11(4):1591–1602.
   PubMed Web of Science ®Google Scholar
• Imam SS, Aqil M, Akhtar M, et al. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Deliv. 2015;22(8):1059–1070.
   PubMed Web of Science ®Google Scholar
• Fahmy AM, Hassan M, El-Setouhy DA, et al. Voriconazole ternary micellar systems for the treatment of ocular mycosis: statistical optimization and in vivo evaluation. J Pharm Sci. 2020.DOI:10.1016/j.xphs.2020.12.013
   Google Scholar
• Mishra A, Kapoor A, Bhargava S. Proniosomal gel as a carrier for transdermal drug delivery of Clotrimazole. Int J Pharm Pharm Sci. 2012;4(Suppl 4):610–614.
   Google Scholar
• Said M, Elsayed I, Aboelwafa AA, et al. Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability. Drug Deliv. 2017;24(1):1159–1169.
   PubMed Web of Science ®Google Scholar
• Rahman SMH, Telny TC, Ravi TK, et al. Role of surfactant and pH in dissolution of curcumin. Indian J Pharm Sci. 2009;71(2):139–142.
   PubMed Web of Science ®Google Scholar
• Shamma RN, Elsayed I. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res. 2013; 23(3):244–254.
   PubMed Web of Science ®Google Scholar
• Fahmy A M, Hassan M, El-Setouhy D A, et al. Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design: in vitro characterization and in vivo evaluation. Drug Delivery. 2021;28(1):77–86. doi:10.1080/10717544.2020.1858997.
   PubMed Web of Science ®Google Scholar
• Aziz DE, Abdelbary AA, Elassasy AI. Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study. J Liposome Res. 2019;29(1):73–85.
   PubMed Web of Science ®Google Scholar
• Tata PN, Fu CH, Bramer SL. Determination of cilostazol and its metabolites in human urine by high performance liquid chromatography. J Pharm Biomed Anal. 2001;24(3):381–389.
   PubMed Web of Science ®Google Scholar
• Fahmy AM, El-Setouhy DA, Ibrahim AB, et al. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Drug Deliv. 2018;25(1):12–22.
   PubMed Web of Science ®Google Scholar
• Radwan SAA, ElMeshad AN, Shoukri RA. Microemulsion loaded hydrogel as a promising vehicle for dermal delivery of the antifungal sertaconazole: design, optimization and ex vivo evaluation. Drug Dev Ind Pharm. 2017;43(8):1351–1365.
   PubMed Web of Science ®Google Scholar
• Banchroft JD, Stevens A, Turner DR. Theory and practice of histological techniques. 4th ed. Vol. 183. New York: Churchil Livingstone; 1996. p. 243–244.
   Google Scholar
• Moghddam SRM, Ahad A, Aqil M, et al. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. Mater Sci Eng C. 2016;69:789–797.
   PubMed Web of Science ®Google Scholar
• Fouda NH, Abdelrehim RT, Hegazy DA, et al. Sustained ocular delivery of dorzolamide-HCL via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Drug Deliv. 2018;25(1):1340–1349.
   PubMed Web of Science ®Google Scholar
• Scognamiglio I, De Stefanob D, Campani V, et al. Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm. 2013;440(2):179–187.
   PubMed Web of Science ®Google Scholar
• Rychter M, Milanowski B, Grześkowiak BF, et al. Cilostazol-loaded electrospun three-dimensional systems for potential cardiovascular application: effect of fibers hydrophilization on drug release, and cytocompatibility. J Colloid Interface Sci. 2019;536:310–327.
   PubMed Web of Science ®Google Scholar
• El-Hadidy GN, Ibrahim HK, Mohamed MI, et al. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm. 2012;38(1):64–72.
   PubMed Web of Science ®Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol. 2011;16(1):44–56.
   PubMed Web of Science ®Google Scholar
• Ramkanth S, Chetty CM, Sudhakar Y, et al. Development, characterization and in vivo evaluation of proniosomal based transdermal delivery system of Atenolol. Futur J Pharm Sci. 2018;4(1):e0003.
   Web of Science ®Google Scholar
• Hao YM, Li K. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Int J Pharm. 2011;403(1–2):245–253.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, et al. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002;244(1–2):73–80.
   PubMed Web of Science ®Google Scholar
• Fahmy A M, El-Setouhy D A, Habib B A, et al. Enhancement of Transdermal Delivery of Haloperidol via Spanlastic Dispersions: Entrapment Efficiency vs. Particle Size. AAPS Pharmscitech. 2019;20(3) doi:10.1208/s12249-019-1306-2.
   Web of Science ®Google Scholar
• Bawazeer S, El-Telbany DFA, Al-Sawahli MH, et al. Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats. Drug Deliv. 2020;2020:1218–1230.
   Google Scholar
• Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv. 2017;24(1):309–319.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jing Q, Hu H, et al. Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential. Int J Pharm. 2020;580:119183.
   PubMed Web of Science ®Google Scholar
• Nowroozi F, Almasi A, Javidi J, et al. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iran J Pharm Res. 2018;17(Suppl 2):1–11.
   PubMedGoogle Scholar
• Bernsdorff C, Wolf A, Winter R, et al. Effect of hydrostatic pressure on water penetration and rotational dynamics in phospholipid-cholesterol bilayers. Biophys J. 1997;72(3):1264–1277.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Bakshi V, Vitta P, et al. Effect of cholesterol content and surfactant HLB on vesicle properties of niosomes. Indian J Pharm Sci. 2004;66(1):121–123.
   Google Scholar
• Sankhyan A, Pawar PK. Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization. DARU, J Pharm Sci. 2013;21(1):7.
   Google Scholar
• Obeid MA, Khadra I, Mullen AB, et al. The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics. Int J Pharm. 2017;516(1–2):52–60.
   PubMed Web of Science ®Google Scholar
• Giannavola C, Bucolo U, Maltese A, et al. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm Res. 2003;20(4):584–590.
   PubMed Web of Science ®Google Scholar
• Sun Z, Nicolosi V, Rickard D, et al. Quantitative evaluation of surfactant-stabilized single-walled carbon nanotubes: dispersion quality and its correlation with zeta potential. J Phys Chem C. 2008;112(29):10692–10699.
   Web of Science ®Google Scholar
• Ogiso T, Niinaka N, Iwaki M. Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. J Pharm Sci. 1996;85(1):57–64.
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Mönkkönen J, Saukkosaari M, et al. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release. 1999;58(2):207–214.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta – Biomembr. 2001;1514(2):191–205.
   PubMed Web of Science ®Google Scholar